PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Centre Léon Bérard Cancer Center, Lyon, France.\', \'Department of Pharmacy, Centre Léon Bérard Cancer Center, Lyon, France.\', \'Department of Medecine of Health Care Workers, Centre Léon Bérard Cancer Center, Lyon, France.\', \'Department DCSEI, Centre Léon Bérard Cancer Center, Lyon, France.\', \'Department of Surgery, Centre Léon Bérard Cancer Center, Lyon, France.\', \'Department of Clinical Research, Centre Léon Bérard Cancer Center, Lyon, France.\', \'Department of Medical Oncology, Centre Léon Bérard Cancer Center, Lyon, France; Faculté de Médecine Lyon Est, Université Claude Bernard Lyon 1, France; Presidence, Unicancer, Paris, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0959-8049(22)00068-510.1016/j.ejca.2022.01.035
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 35245864
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all